Fate Therapeutics, Inc. (FATE)
NASDAQ: FATE · Real-Time Price · USD
1.680
+0.020 (1.20%)
Dec 20, 2024, 4:00 PM EST - Market closed
Fate Therapeutics Income Statement
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | 2018 - 2014 |
|---|---|---|---|---|---|---|---|
Period Ending | Sep '24 Sep 30, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | Dec '19 Dec 31, 2019 | 2018 - 2014 |
| Revenue | 13.45 | 63.53 | 96.3 | 55.85 | 31.43 | 10.68 | Upgrade
|
| Revenue Growth (YoY) | -87.34% | -34.03% | 72.44% | 77.66% | 194.33% | 125.32% | Upgrade
|
| Cost of Revenue | 122.31 | 161.7 | 320.45 | 215.52 | 125.62 | 87.77 | Upgrade
|
| Gross Profit | -108.86 | -98.16 | -224.15 | -159.67 | -94.19 | -77.09 | Upgrade
|
| Selling, General & Admin | 74.84 | 79.45 | 84.23 | 57.32 | 33.9 | 23.64 | Upgrade
|
| Operating Expenses | 74.84 | 79.45 | 84.23 | 57.32 | 33.9 | 23.64 | Upgrade
|
| Operating Income | -183.7 | -177.61 | -308.39 | -216.99 | -128.09 | -100.73 | Upgrade
|
| Interest Expense | - | - | - | - | - | -1.75 | Upgrade
|
| Interest & Investment Income | 17.83 | 17.19 | 5.84 | 1.31 | 2.4 | 4.33 | Upgrade
|
| Other Non Operating Income (Expenses) | -4.56 | 7.3 | 20.32 | 3.53 | -47.7 | - | Upgrade
|
| EBT Excluding Unusual Items | -170.43 | -153.13 | -282.22 | -212.15 | -173.39 | -98.15 | Upgrade
|
| Merger & Restructuring Charges | -12.9 | -12.9 | - | - | - | - | Upgrade
|
| Other Unusual Items | 5.1 | 5.1 | 0.5 | - | - | - | Upgrade
|
| Pretax Income | -178.23 | -160.93 | -281.72 | -212.15 | -173.39 | -98.15 | Upgrade
|
| Net Income | -178.23 | -160.93 | -281.72 | -212.15 | -173.39 | -98.15 | Upgrade
|
| Net Income to Common | -178.23 | -160.93 | -281.72 | -212.15 | -173.39 | -98.15 | Upgrade
|
| Shares Outstanding (Basic) | 109 | 98 | 97 | 95 | 82 | 68 | Upgrade
|
| Shares Outstanding (Diluted) | 109 | 98 | 97 | 95 | 82 | 68 | Upgrade
|
| Shares Change (YoY) | 11.03% | 1.64% | 2.19% | 15.01% | 20.82% | 21.35% | Upgrade
|
| EPS (Basic) | -1.64 | -1.64 | -2.91 | -2.24 | -2.10 | -1.44 | Upgrade
|
| EPS (Diluted) | -1.64 | -1.64 | -2.91 | -2.24 | -2.10 | -1.44 | Upgrade
|
| Free Cash Flow | -132.52 | -138.42 | -283.77 | -213.57 | -44.16 | -90.57 | Upgrade
|
| Free Cash Flow Per Share | -1.22 | -1.41 | -2.93 | -2.25 | -0.54 | -1.33 | Upgrade
|
| Gross Margin | - | -154.51% | -232.77% | -285.92% | -299.64% | - | Upgrade
|
| Operating Margin | -1366.13% | -279.56% | -320.23% | -388.56% | -407.47% | -943.14% | Upgrade
|
| Profit Margin | -1325.43% | -253.30% | -292.55% | -379.89% | -551.59% | -919.00% | Upgrade
|
| Free Cash Flow Margin | -985.54% | -217.86% | -294.68% | -382.43% | -140.49% | -848.03% | Upgrade
|
| EBITDA | -164.67 | -159.33 | -294.63 | -211.14 | -125 | -98.53 | Upgrade
|
| EBITDA Margin | - | -250.78% | - | - | - | - | Upgrade
|
| D&A For EBITDA | 19.03 | 18.28 | 13.76 | 5.85 | 3.09 | 2.19 | Upgrade
|
| EBIT | -183.7 | -177.61 | -308.39 | -216.99 | -128.09 | -100.73 | Upgrade
|
| EBIT Margin | - | -279.56% | - | - | - | - | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.